TP53 and glioma: Prognostic effects of TP53 mutations have been studied extensively; however, no concordance between the outcomes of individual studies was observed [19,24,25,26,27,28], possibly because the histological subtypes associated with different OS were combined as one cohort of either LGG or glioma, particularly in survival studies, which led to discordant results.